<MedlineCitation Status="Completed">
<MedlineID>10011196</MedlineID>
<PMID>84679</PMID>
<DateCreated>
<Year>1979</Year>
<Month>05</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>05</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0007-1048</ISSN>
<JournalIssue>
<Volume>41</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1979</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>Subtypes of i demonstrated by the use of atypical Ii cell types and inhibition studies.</ArticleTitle>
<Pagination>
<MedlinePgn>105-13</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Haemagglutination, absorption and elution studies with several anti-i sera and atypical Ii red cell types and Oh cells were carried out and three subtypes of specificity were demonstrated. The fourth i subtype was demonstrated by an inhibition method using human serum and amniotic fluid as a source of i substance.</AbstractText>
</Abstract>
<AuthorList>
<Author>
<LastName>Dzierzkowa-Borodej</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author>
<LastName>Voak</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>ENGLAND</Country>
<MedlineTA>Br J Haematol</MedlineTA>
<NlmUniqueID>0372544</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Blood Groups</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Epitopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>I Blood-Group System</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Agglutination Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Amniotic Fluid</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Blood Groups</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Classification</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Epitopes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Hemagglutination Inhibition Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Human</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">I Blood-Group System</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Phenotype</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
